Skip to content

RADAR pilot study

RADAR pilot study - RADAR

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00016924
Enrollment
100
Registered
2019-03-13
Start date
2019-03-08
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Z92.1

Interventions

Group 1: Quality of life of participating patients who receive a long-term therapy with anti-coagulants. Quality of life will be measured with the EQ-5D questionnaire and linked to the patients routin

Sponsors

Institut für AllgemeinmedizinUniversitätsmedizin Göttingen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Particpants must be at least 18 years of age and receive a long-term anti-coagulant therapy

Exclusion criteria

Exclusion criteria: Excluded are patients with dementia and patients who have low German language skills and who are unable to understand the study information and its implications.

Design outcomes

Primary

MeasureTime frame
The technical/organizational goal of the RADAR pilot study is to test the infrastructure of the RADAR project with regards to (1) the export of routine data from local primary care practices, (2) the collection of primary data about quality of life through a trusted-third party and (3) linkage of the primary and secondary data according to data protection laws.

Secondary

MeasureTime frame
The content-related goal of the RADAR pilot study is to investigate how patients who receive a long-term therapy with anti-coagulants rate their quality of life.

Countries

Germany

Contacts

Public ContactStephanie Heinemann

Institut für AllgemeinmedizinUniversitätsmedizin Göttingen

sheinem3@gwdg.de0551 39-9668

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026